Citations

Clear

151 citation(s) found for "Mathieu, D".

CUTE‐CV: A Prospective Study of Enhanced Left Atrial Appendage Visualization with Microbubble Contrast Agent Use during Transesophageal Echocardiography Guided Cardioversion
Bernier, Mathieu , Moir, William, Rain, Susan J. Eifert, Chandrasekaran, Krishnaswamy , Ammash, Naser M., Abdelmoneim, Sahar S. , Mulvagh, Sharon L.

Mayo Clinic

Echocardiography | May 11, 2013 | Volume: 30 | Issue: 9 | Pages: 1091-1097

10.1111/echo.12240 | PMID 23662846 Get It

ObjectivesThe aim of our study was to demonstrate that the use of contrast microbubbles during transesophageal echocardiography (TEE) guided cardioversion will improve interpretation of the TEE images.BackgroundTEE‐guided cardioversion of atrial flutter or fibrillation (AF) is a safe and proven method to restore sinus rhythm. However, artifacts and dense spontaneous echo contrast in the left atrial appendage (LAA) can sometimes decrease the level of confidence in excluding the presence of thrombus.MethodsOne hundred patients referred for TEE‐guided cardioversion were prospectively enrolled and microbubble contrast agent (DEFINITY) was administered after the clinical decision had been made regarding suitability for cardioversion. Noncontrast and contrast images were compared during subsequent offline analysis.ResultsLAA dimensions and contractility indices were higher, artifacts were significantly differentiated, previously unsuspected LAA filling defects were identified, and the level of confidence in excluding thrombus was enhanced in the contrast images when compared to the noncontrast images. After 4 months follow‐up, 1 stroke‐associated death occurred in a patient who had LAA thrombus recognized only by contrast. Left atrial appendage visualization is enhanced with microbubble contrast agent use during transesophageal echocardiography guided cardioversion and is useful in identification of intracardiac thrombus.
A Multicenter, Prospective Study to Evaluate the Use of Contrast Stress Echocardiography in Early Menopausal Women at Risk for Coronary Artery Disease: Trial Design and Baseline Findings
Bernier, Mathieu , Hagen, Mary E., Eifert-Rain, Susan, Bott‐Kitslaar, Dalene , Wilansky, Susan , Castelló, Ramón, Bhat, Gajanan , Pellikka, Patricia A. , Best, Patricia J.M. , Hayes, Sharonne N. , Abdelmoneim, Sahar S. , Mulvagh, Sharon L. , Pellikka, Patricia A , Hayes, Sharonne N

Mayo Clinic

Journal of Women's Health | February 11, 2013 | Volume: 22 | Issue: 2 | Pages: 173-183

10.1089/jwh.2012.3714 | PMID 23398128 Get It

Nectin-4-Dependent Measles Virus Spread to the Cynomolgus Monkey Tracheal Epithelium: Role of Infected Immune Cells Infiltrating the Lamina Propria
Frenzke, Marie, Sawatsky, Bevan , Wong, Xiao X., Delpeut, Sébastien, Mateo, Mathieu , Cattaneo, Roberto , Messling, Veronika von

Mayo Clinic

Journal of Virology | December 20, 2012 | Volume: 87 | Issue: 5 | Pages: 2526-2534

10.1128/jvi.03037-12 | PMID 23255790 Get It

ABSTRACT After the contagion measles virus (MV) crosses the respiratory epithelium within myeloid cells that express the primary receptor signaling lymphocytic activation molecule (SLAM), it replicates briskly in SLAM-expressing cells in lymphatic organs. Later, the infection spreads to epithelia expressing nectin-4, an adherens junction protein expressed preferentially in the trachea, but how it gets there is not understood. To characterize the mechanisms of spread, we infected groups of 5 or 6 cynomolgus monkeys ( Macaca fascicularis ) with either a wild-type MV or its “N4-blind” derivative, which is unable to enter nectin-4-expressing cells because of the targeted mutation of two hemagglutinin residues. As expected, both viruses caused similar levels of immunosuppression, as monitored by reductions in white blood cell counts and lymphocyte proliferation activity. However, monkeys infected with the N4-blind MV cleared infection more rapidly. Wild-type virus-infected monkeys secreted virus, while marginal virus titers were detected in tracheal lavage fluid cells of N4-blind MV-infected hosts. Analyses of tracheal rings obtained at necropsy (day 12) documented widespread infection of individual cells or small cell clusters in the subepithelial lamina propria of monkeys infected with either virus. However, only wild-type MV spread to the epithelium, forming numerous infectious centers comprised of many contiguous columnar cells. Infected CD11c + myeloid (macrophage or dendritic) cells were frequently observed in the lamina propria below epithelial infectious centers. Thus, MV may use myeloid cells as vehicles not only immediately after contagion but also to infect epithelia of tissues expressing nectin-4, including the trachea.
The Microculture-Kinetic (MiCK) Assay: The Role of a Drug-Induced Apoptosis Assay in Drug Development and Clinical Care
Prendergast, Franklyn G., Fleisher, Martin, Salom, Emery, Strickland, Stephen A. , Raptis, Anastasios, Hallquist, Allan, Perrée, Mathieu, Rajurkar, Swapnil, Karimi, Misagh, Rogers, Karl, Davidson, Dirk, Willis, C. , Peñalver, Manuel, Homesley, Howard D., Burrell, Matthew O., Garrett, Audrey P., Rutledge, James, Chernick, Michael R., Presant, Cary A. , Bosserman, Linda D. , Herbst, Roy S. , Strickland, Stephen Anthony

Mayo Clinic

Cancer Research | August 4, 2012 | Volume: 72 | Issue: 16 | Pages: 3901-3905

10.1158/0008-5472.can-12-0681 | PMID 22865459 Get It

Abstract A drug-induced apoptosis assay, termed the microculture-kinetic (MiCK) assay, has been developed. Blinded clinical trials have shown higher response rates and longer survival in groups of patients with acute myelocytic leukemia and epithelial ovarian cancer who have been treated with drugs that show high apoptosis in the MiCK assay. Unblinded clinical trials in multiple tumor types have shown that the assay will be used frequently by clinicians to determine treatment, and when used, results in higher response rates, longer times to relapse, and longer survivals. Model economic analyses suggest possible cost savings in clinical use based on increased generic drug use and single-agent substitution for combination therapies. Two initial studies with drugs in development are promising. The assay may help reduce costs and speed time to drug approval. Correlative studies with molecular biomarkers are planned. This assay may have a role both in personalized clinical therapy and in more efficient drug development. Cancer Res; 72(16); 3901–5. ©2012 AACR.
Large-scale replication and heterogeneity in Parkinson disease genetic loci
Sharma, Manu , Aasly, Jan , Annesi, Grazia , Brice, Alexis , Broeckhoven, Christine Van , Bozi, Maria , Crosiers, David , Clarke, Carl E , Facheris, Maurizio , Farrer, Matthew J. , Garraux, Gaëtan , Gispert, Suzana, Auburger, Georg , Vilariño‐Güell, Carles , Hicks, Andrew A. , Hattori, Nobutaka , Jeon, Beom S., Lesage, Suzanne , Lill, Christina M. , Lin, Juei-Jueng, Lynch, Timothy , Lichtner, Peter , Lang, Anthony E. , Jasińska‐Myga, Barbara, Mellick, George D. , Morrison, Karen , Opala, Grzegorz, Pramstaller, Peter P. , Pichler, Irene , Park, Sung Sup , Quattrone, Aldo , Ross, Owen A. , Stockton, Joanne , Satake, Wataru , Silburn, Peter A., Theuns, Jessie , Tan, Eng-King, Tomiyama, Hiroyuki , Uitti, Ryan J. , Wirdefeldt, Karin , Xiromerisiou, Georgia , Yueh, Kuo-Chu, Zhao, Yi , Gasser, Thomas , Maraganore, Demetrius M. , Krüger, Rejko , Boyle, R.S, Sellbach, A, Siebert, G., Pickut, Barbara , Engelborghs, Sebastiaan , Meeus, Bram, Deyn, Peter Paul De, Cras, Patrick , Agid, Yves, Anheim, Mathieu , Bonnet, A-M, Broussolle, E. , Corvol, Jean‐Christophe , Destée, A., Durif, F., Lesage, Suzanne , Lohmann, Ebba , Pollak, Pierre, Rascol, Olivier , Tison, François , Viallet, François, Amouyel, Philippe , Loriot, Marie‐Anne , Mutez, Eugénie , Duflot, Aurélie , Legendre, Jean-Philippe, Waucquier, Nawal, Schulte, Claudia , Klein, Christine , Djarmati, Ana, Hagenah, Johann, Lohmann, Katja , Hilker, Rüdiger, Loo, Simone van de, Tsimourtou, Vaïa, Ralli, Styliani, Kountra, Persa, Patramani, Gianna, Vogiatzi, Cristina, Hattori, Nobutaka, Yoshino, Hiroyo , Li, Yuanzhe, Imamichi, Yoko, Gibson, J. Mark , Ialongo, Tàmara, Brighina, Laura , Corradi, B., Piolti, Roberto, Tarantino, Patrizia, Kłodowska-Duda, Gabriela, Boczarska‐Jedynak, Magdalena , Tan, Eng King, Olson, Lars, Westerlund, Marie, Sydow, Olof , Puschmann, Andreas , Lin, J-J , J, Eric Ahlskog, Lesnick, Timothy G. , Rocca, Walter A. , Checkoway, Harvey , Westenberger, Ana , Ioannidis, John P. A. , Bertram, Lars , Hadjigeorgiou, Georgios M. , Mok, Vincent , Rogaeva, Ekaterina A. , Stefanis, Leonidas , Toda, Tatsushi , Wszołek, Zbigniew K. , O’Sullivan, John D. , Sutherland, Greg T. , Dissanayaka, Nadeeka N. , Borg, Michael , Damier, Philippe , Dürr, Alexandra , Tranchant, Christine , Vidailhet, Marie , Tzourio, Christophe , Rieß, Olaf , Berg, Daniela , Dardiotis, Efthimios , Funayama, Manabu , Valente, Enza Maria , Ferraris, Alessandro , Dallapiccola, Bruno , Annesi, Ferdinanda , Belin, Andrea Carmine , Olson, Lars, Galter, Dagmar , Nilsson, Christer C. , Andrade, Mariza de , Lang, Anthony E , Ross, Owen A , Puschmann, Andreas , Klein, Christine , Amouyel, Philippe , Corvol, Jean-Christophe , Mutez, Eugénie , Schulte, Claudia , Brice, Alexis

Mayo Clinic

Neurology | July 12, 2012 | Volume: 79 | Issue: 7 | Pages: 659-667

10.1212/wnl.0b013e318264e353 | PMID 22786590 Get It

Gamma Knife surgery for the management of glomus tumors: a multicenter study
Sheehan, Jason P. , Tanaka, Shota , Link, Michael J. , Pollock, Bruce E. , Mathieu, David , Duma, Christopher , Young, A. Byron, Kaufmann, Anthony M. , McBride, Heyoung L., Weisskopf, Peter A., Xu, Zhiyuan , Kano, Hideyuki , Lunsford, L. Dade , Kondziolka, Douglas , Yang, Huai‐Che , Mathieu, David

Mayo Clinic

Journal of Neurosurgery | June 8, 2012 | Volume: 117 | Issue: 2 | Pages: 246-254

10.3171/2012.4.jns11214 | PMID 22680240 Get It

Object Glomus tumors are rare skull base neoplasms that frequently involve critical cerebrovascular structures and lower cranial nerves. Complete resection is often difficult and may increase cranial nerve deficits. Stereotactic radiosurgery has gained an increasing role in the management of glomus tumors. The authors of this study examine the outcomes after radiosurgery in a large, multicenter patient population. Methods Under the auspices of the North American Gamma Knife Consortium, 8 Gamma Knife surgery centers that treat glomus tumors combined their outcome data retrospectively. One hundred thirty-four patient procedures were included in the study (134 procedures in 132 patients, with each procedure being analyzed separately). Prior resection was performed in 51 patients, and prior fractionated external beam radiotherapy was performed in 6 patients. The patients' median age at the time of radiosurgery was 59 years. Forty percent had pulsatile tinnitus at the time of radiosurgery. The median dose to the tumor margin was 15 Gy. The median duration of follow-up was 50.5 months (range 5–220 months). Results Overall tumor control was achieved in 93% of patients at last follow-up; actuarial tumor control was 88% at 5 years postradiosurgery. Absence of trigeminal nerve dysfunction at the time of radiosurgery (p = 0.001) and higher number of isocenters (p = 0.005) were statistically associated with tumor progression–free tumor survival. Patients demonstrating new or progressive cranial nerve deficits were also likely to demonstrate tumor progression (p = 0.002). Pulsatile tinnitus improved in 49% of patients who reported it at presentation. New or progressive cranial nerve deficits were noted in 15% of patients; improvement in preexisting cranial nerve deficits was observed in 11% of patients. No patient died as a result of tumor progression. Conclusions Gamma Knife surgery was a well-tolerated management strategy that provided a high rate of long-term glomus tumor control. Symptomatic tinnitus improved in almost one-half of the patients. Overall neurological status and cranial nerve function were preserved or improved in the vast majority of patients after radiosurgery.
Detection of myocardial microvascular disease using contrast echocardiography during adenosine stress in type 2 diabetes mellitus: Prospective comparison with single-photon emission computed tomography
Abdelmoneim, Sahar S. , Basu, Ananda , Bernier, Mathieu , Dhoble, Abhijeet , Abdel‐Kader, Samir S., Pellikka, Patricia A. , Mulvagh, Sharon L. , Pellikka, Patricia A

Mayo Clinic

Diabetes and Vascular Disease Research | September 20, 2011 | Volume: 8 | Issue: 4 | Pages: 254-261

10.1177/1479164111419973 | PMID 21933841 Get It

Purrpose: To evaluate myocardial microvascular disease in patients with type 2 diabetes mellitus (DM) using myocardial contrast echocardiography (MCE) and to report on its diagnostic accuracy using single photon emission tomography (SPECT) as reference test. Methods: We prospectively enrolled 79 patients (25 DM; 66±11 years) who underwent simultaneous SPECT and MCE with contrast agent during adenosine stress. MCE and SPECT were visually analyzed using 17 segments. Quantitative MCE parameters were derived from replenishment curves. Microbubble velocity (β min −1 ), absolute myocardial blood flow (MBF ml/min/g), and reserve values were calculated. Diagnostic accuracy and area under curve (AUC) was reported. Results: Patients with DM had higher BMI vs non DM (33±7 vs 28±5kg/m 2 P=0 .007), with more prior myocardial infarction (40 vs 15% P=.01). Visual MCE was abnormal in 40 (51%) patients (60% in DM vs 46% in non DM P=0.04). SPECT was abnormal in 38 (48%) patients [60% in DM vs 42% non DM, P=0.01]. Reserve parameters were lower in DM vs. non DM patients: (β 1.77±1.12 vs 2.20±1.4, P<0.001 and MBF 2.86± 2.62 vs. 3.67±2.84, P<0.001). DM patients without CAD on SPECT had significantly lower β, and MBF reserve compared to non DM patients without CAD. Compared to SPECT, β reserve cutoff 1.6 had AUC 0.817, sensitivity 81%, and specificity 66% while MBF reserve cutoff 1.9 had AUC 0.760, sensitivity 79%, and specificity 63% in DM patients. Conclusion: Diabetes is associated with myocardial microvascular abnormalities as evidenced by abnormal myocardial perfusion on visual and quantitative MCE.
Stereotactic radiosurgery for intractable cluster headache: an initial report from the North American Gamma Knife Consortium
Kano, Hideyuki , Mathieu, David , Stafford, Scott L., Flannery, Thomas , Niranjan, Ajay, Pollock, Bruce E. , Kaufmann, Anthony M. , Flíckinger, John C. , Lunsford, L. Dade , Kondziolka, Douglas , Niranjan, Ajay, Mathieu, David

Mayo Clinic

Journal of Neurosurgery | April 30, 2010 | Volume: 114 | Issue: 6 | Pages: 1736-1743

10.3171/2010.3.jns091843 | PMID 20433278 Get It

Object The aim of this study was to evaluate the outcomes of Gamma Knife surgery (GKS) when used for patients with intractable cluster headache (CH). Methods Four participating centers of the North American Gamma Knife Consortium identified 17 patients who underwent GKS for intractable CH between 1996 and 2008. The median patient age was 47 years (range 26–83 years). The median duration of pain before GKS was 10 years (range 1.3–40 years). Seven patients underwent unsuccessful prior surgical procedures, including microvascular decompression (2 patients), microvascular decompression with glycerol rhizotomy (2 patients), deep brain stimulation (1 patient), trigeminal ganglion stimulation (1 patient), and prior GKS (1 patient). Fourteen patients had associated autonomic symptoms. The radiosurgical target was the trigeminal nerve (TN) root and the sphenopalatine ganglion (SPG) in 8 patients, only the TN in 8 patients, and only the SPG in 1 patient. The median maximum TN and SPG dose was 80 Gy. Results Favorable pain relief (Barrow Neurological Institute Grades I–IIIb) was achieved and maintained in 10 (59%) of 17 patients at a median follow-up of 34 months. Three patients required additional procedures (repeat GKS in 2 patients, hypothalamic deep brain stimulation in 1 patient). Eight (50%) of 16 patients who had their TN irradiated developed facial sensory dysfunction after GKS. Conclusions Gamma Knife surgery for intractable, medically refractory CH provided lasting pain reduction in approximately 60% of patients, but was associated with a significantly greater chance of facial sensory disturbances than GKS used for trigeminal neuralgia.
Safety of Contrast Agent Use During Stress Echocardiography in Patients With Elevated Right Ventricular Systolic Pressure
Abdelmoneim, Sahar S. , Bernier, Mathieu , Scott, Christopher G. , Dhoble, Abhijeet , Ness, Sue Ann C., Hagen, Mary E., Moir, Stuart , McCully, Robert B. , Pellikka, Patricia A. , Mulvagh, Sharon L. , Scott, Christopher , Pellikka, Patricia A

Mayo Clinic

Circulation: Cardiovascular Imaging | March 17, 2010 | Volume: 3 | Issue: 3 | Pages: 240-248

10.1161/circimaging.109.895029 | PMID 20233859 Get It

Background— Microbubble safety concerns led to changes in product recommendations for patients with pulmonary hypertension. Noninvasive estimation of right ventricular systolic pressure (RVSP) is equivalent to pulmonary artery systolic pressure in the absence of pulmonary outflow obstruction. We analyzed the short- and long-term outcomes of patients who received microbubble contrast and those who did not during stress echocardiography (SE) according to resting RVSP. Methods and Results— From November 2003 to December 2007, 26 774 patients underwent SE. RVSP (mean, 32.6�9.6 mm Hg) was measured in 16 434 patients. Of these, 6164 (37.5%) received contrast for left ventricular opacification and 10 270 (62.5%) did not. Short-term (≤72 hours and ≤30 days) and long-term (4.3 years) end points were death and myocardial infarction. Analysis was done for rest RVSP cut-points ≥35, ≥50, and ≥60 mm Hg and tricuspid regurgitant velocities ≥2.7 ms −1 and ≥3.5 ms −1 . Adjusted Cox regression models were used. The contrast cohort comprised older patients (age, 67�12 versus 64�14 years; P <0.001), who were more likely to have positive SE results (35% versus 30%, P <0.001) compared with the noncontrast cohort. Using RVSP ≥50 mm Hg, there was no significant difference in short-term events between the contrast and noncontrast cohorts. For long-term events, there was no significant difference between both cohorts (adjusted hazard ratios [95% confidence intervals] for death, 1.10 [0.80 to 1.50], P =0.56; and myocardial infarction, 0.34 [0.11 to 1.03], P =0.06). Similar results were obtained at different RVSP and tricuspid regurgitant cut-points. Contrast agent–related adverse effects occurred in <1% of patients. Conclusion— RVSP had no impact on predisposition to adverse outcomes in patients undergoing contrast SE in the population studied.
Real-time myocardial perfusion contrast echocardiography and regional wall motion abnormalities after aneurysmal subarachnoid hemorrhage
Abdelmoneim, Sahar S. , Lee, Vivien , Daugherty, Wilson P., Bernier, Mathieu , Oh, Jae K. , Pellikka, Patricia A. , Wijdicks, Eelco F. M. , Mulvagh, Sharon L. , Pellikka, Patricia A

Mayo Clinic

Journal of Neurosurgery | April 24, 2009 | Volume: 111 | Issue: 5 | Pages: 1023-1028

10.3171/2009.3.jns081723 | PMID 19392602 Get It

Object The pathophysiology of myocardial dysfunction after subarachnoid hemorrhage (SAH) remains unclear. Using myocardial real-time perfusion contrast echocardiography (RTP-CE), the authors evaluated microvascular function in patients with acute SAH. Methods Over a 15-month period, 10 patients with acute SAH and evidence of cardiac dysfunction were prospectively enrolled. The authors performed RTP-CE within 48 hours of SAH diagnosis. Wall motion and myocardial perfusion were evaluated in 16 left ventricle segments. Qualitative and quantitative RTP-CE analyses were conducted to compare patients with and without regional wall motion abnormalities (RWMAs). Follow-up RTP-CE at a mean of 53.7 ± 43 days was undertaken in patients with baseline RWMAs. Results Ten patients with SAH and evidence of cardiac dysfunction were prospectively enrolled. There were 3 men and 7 women whose mean age was 63.5 ± 10.1 years. The authors documented evidence of RWMAs in 6 patients. Normal perfusion was demonstrated by RTP-CE in all patients at baseline and follow-up, despite the presence of RWMAs. Compared with patients presenting with normal wall motion, in patients with RWMAs there was a trend for higher quantitative RTP-CE parameters, suggesting hyperemia with mean myocardial blood flow velocity (β, s−1) of 1.08 ± 0.61 (95% CI 0–2.61) compared with 1.62 ± 0.64 (95% CI 0.94–2.29) and myocardial blood flow (A × β, dB/s) of 0.99 ± 0.41 (95% CI 0–2.0) versus 1.63 ± 0.86 (95% CI 0.72–2.53). Follow-up RTP-CE was feasible in 3 patients with RWMAs. Regional systolic function was restored in those who completed follow-up. Conclusions The authors found that RTP-CE readily evaluates microvascular function in patients with SAH. Wall motion and perfusion dissociation were observed. Quantitative RTP-CE showed a trend for microvascular hyperemia in patients with RWMAs, suggesting that post-SAH myocardial dysfunction could occur in the absence of microvascular dysfunction.